Newron Pharmaceuticals S.p.A. (SWX:NWRN)
30.40
+1.95 (6.85%)
At close: Jan 9, 2026
Revenue by Product
Financials in millions CHF. Fiscal year is January - December.
Millions CHF. Fiscal year is Jan - Dec.
Revenue by Geography
Financials in millions CHF. Fiscal year is January - December.
Millions CHF. Fiscal year is Jan - Dec.